How long semaglutide stays in your body: Ozempic's half-life explained

If you have taken Ozempic, or are thinking about stopping it, you may wonder how long it stays in your body. The answer comes from its half-life: the time it takes for the amount of a drug in your blood to fall by half. This guide explains Ozempic's half-life using the FDA-approved labels, and what it means for missed doses, stopping, switching, surgery, and pregnancy.

It is educational content, not medical advice. Decisions about starting, stopping, or changing a medication belong to you and a licensed provider.

Ozempic's half-life and why it allows weekly dosing

Ozempic contains semaglutide, which has an elimination half-life of about one week [1]. That is long for a medication, and it is the reason Ozempic is injected once a week instead of daily.

The long half-life comes from the molecule's design. More than 99% of semaglutide in the blood is bound to albumin, a blood protein [2]. That binding slows clearance by the kidneys and protects the drug from breakdown [2]. After an injection, levels peak one to three days later [2].

How long it takes to clear the body

The Ozempic label states that semaglutide will be present in circulation for about five weeks after the last dose [1]. The Wegovy label, which covers higher doses, puts it at about five to seven weeks after the last 2.4 mg or 7.2 mg injection or the last 25 mg tablet [2].

A general rule in pharmacology is that a drug is mostly cleared after about five half-lives. With a one-week half-life, that lines up with the five-week figure.

"Present in circulation" does not mean you notice its effects for that whole time. Drug levels fall steadily, and effects such as reduced appetite tend to fade as levels drop. How that feels varies from person to person.

What half-life means for missed doses

Because semaglutide lingers, a missed dose does not drop levels to zero. The labels still give specific instructions:

• Ozempic: take the missed dose as soon as possible within five days of the missed dose. If more than five days have passed, skip it and resume on the regular day [1].
• Wegovy injection: if the next scheduled dose is more than two days away, take the missed dose as soon as possible. If it is less than two days away, skip it [2].
• Two or more missed Wegovy doses: the label says to restart dose escalation at a lower dose to reduce the risk of gastrointestinal side effects [2].

If you take a compounded formulation, ask your provider which rule applies to you.

What it means when stopping

When semaglutide is stopped, levels decline gradually over the following weeks [1, 2]. There is no abrupt drop. Our article on whether stopping semaglutide causes withdrawal covers what people commonly notice and how to plan a stop with a provider.

Half-life when switching medications or doses

Because the drug lingers, timing matters when switching. The Wegovy label gives two examples. When moving from the 2.4 mg injection to the 25 mg tablet, the first tablet is taken one week after the last injection [2]. When moving from the tablet to the injection, the first injection is taken the day after the last tablet [2].

The Wegovy label also states that using it with other semaglutide products or any other GLP-1 receptor agonist is not recommended [2]. Any switch, whether between brands, forms, or to a different medication, is planned by your provider. For dose amounts and measurement, see our semaglutide and tirzepatide dosing guide.

How tirzepatide compares

Tirzepatide, the active ingredient in Zepbound and Mounjaro, is also injected once a week. The Zepbound label gives a half-life of about five days [3], somewhat shorter than semaglutide's one week. Its missed-dose window is shorter too: within four days (96 hours) of the missed dose [3].

The Zepbound label adds a practical note. Tirzepatide may reduce how well oral hormonal birth control works, so the label advises switching to a non-oral method or adding a barrier method for four weeks after starting and after each dose increase [3].

A shorter half-life does not make one medication better than the other; they are different drugs with different labels. Our article on tirzepatide versus semaglutide covers other differences.

Half-life and planning around surgery or pregnancy

Surgery and sedation. The labels note rare reports of pulmonary aspiration (inhaling stomach contents) in people taking GLP-1 receptor agonists who had general anesthesia or deep sedation [1, 2]. The Wegovy label says available data are not enough to know whether pausing the medication beforehand reduces this risk [2]. Tell every provider involved in a planned procedure that you take semaglutide.

Pregnancy. Both labels advise stopping semaglutide at least two months before a planned pregnancy, specifically because of its long half-life [1, 2]. If you become pregnant while taking it, contact your provider.

Like any prescription medication, semaglutide carries risks and possible side effects, including a boxed warning about thyroid C-cell tumors seen in rodents [1, 2]. A provider reviews these with you.

Common questions

How long after the last dose is Ozempic out of my system?

The Ozempic label says semaglutide is present in circulation for about five weeks after the last dose [1].

Is oral semaglutide's half-life different?

Oral semaglutide is the same molecule with a similarly long half-life. The Wegovy label says semaglutide remains in circulation for about five to seven weeks after the last 25 mg tablet [2]. Our article on GLP-1 tablets versus injections covers the practical differences.

Can I drink alcohol while it's still in my system?

The semaglutide labels do not set a specific alcohol rule. Alcohol can add to dehydration and stomach upset, and it can raise the risk of low blood sugar in people who also take insulin or a sulfonylurea. Our article on alcohol and GLP-1 medications goes further. If drinking feels hard to control, raise it with a clinician.

Does compounded semaglutide have the same half-life?

Compounded semaglutide contains semaglutide, the molecule studied in FDA-approved products. However, compounded formulations are not FDA-approved and are not evaluated for safety, effectiveness, or quality, so their behavior in the body has not been established the same way. Follow your pharmacy label and your provider's instructions.

Next steps

If you have questions about starting, stopping, or switching a GLP-1 medication, the next step is a conversation with a licensed provider who can review your history and decide whether treatment makes sense for you. Nothing is prescribed or shipped without that review.

Explore Luvo's Weight Loss Program.